eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.54+0.02 (+0.36%)

Delayed quote: Oct 6, 2026, 11:59 AM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T17:02:10.223Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:02:10.223Z.

Quote observation: 2026-10-06T15:59:37.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 51,418,729
Total debt · period ending 2026-06-30: 1,085,035
Cash · period ending 2026-06-30: 5,652,696
TTM operating income · period ending 2026-06-30: -10,558,562

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EXOZ EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

EXOZ Competitors' EV/EBIT Ratio

EXOZ

eXoZymes, Inc.

Current

Market Cap

$51.42M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$51.33M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs EXOZ

Market Cap

$51.54M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs EXOZ

Market Cap

$51.24M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs EXOZ

Market Cap

$51.61M

EV/EBIT Ratio

11.46x

TTM Avg

6.17x

3Y Avg

6.96x

5Y Avg

6.04x

CELU

Celularity Inc.

vs EXOZ

Market Cap

$50.80M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs EXOZ

Market Cap

$50.54M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs EXOZ

Market Cap

$50.38M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs EXOZ

Market Cap

$52.46M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs EXOZ

Market Cap

$52.47M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$51.42M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.54M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$51.24M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.61M	11.46x	6.17x	6.96x	6.04x
Celularity Inc. (CELU)vs ›	$50.80M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.54M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$50.38M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.46M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$52.47M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

EXOZ EV/EBIT Ratio Metrics

EXOZ Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics